Table 2

Combined Outcomes of Death or Arrhythmia

OutcomeSubjects With Event Carvedilol (n = 975)/Placebo (n = 984)Carvedilol/Placebo Hazard Ratio (95% CI)Log-Rank p Value
Death or SV arrhythmia133/1870.70 (0.56, 0.88)0.0016
Death or SV arrhythmia (excluding patients with a history of AF/AFL)112/1520.72 (0.57, 0.92)0.0090
Death or AF/AFL129/1860.68 (0.55, 0.85)0.0008
Death or AF/AFL (excluding patients with a history of AF/AFL)109/1510.71 (0.55, 0.91)0.0057
Death or any ventricular arrhythmia138/2010.67 (0.54, 0.84)0.0003
Death or any ventricular arrhythmia (excluding patients with a history of VT/VF)137/1970.68 (0.54, 0.84)0.0004
Death or a malignant ventricular arrhythmia123/1730.70 (0.56, 0.89)0.0028
Death or any arrhythmia154/2330.64 (0.52, 0.79)<0.0001

AF/AFL = atrial fibrillation/atrial flutter; CI = confidence interval; SV = supraventricular; VT/VF = ventricular tachycardia/ventricular fibrillation.